Atlas Trials

Abatacept for SLE Arthritis (IM101-330)

Clinical trial NCT02429934 · TERMINATED

Trial details

NCT number
NCT02429934
Sponsor
University of California, Los Angeles
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Systemic Lupus Erythematosus Arthritis
Start date
2015-10-01
Primary completion
2019-09-01
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.